BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 23781007)

  • 21. The cross-sectional and longitudinal relationships between white matter hyperintensities and dementia in patients with Parkinson's disease: A retrospective analysis of 132 patients in a single center.
    Lee SJ; Lee DG
    Arch Gerontol Geriatr; 2016; 62():133-7. PubMed ID: 26541556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study.
    Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Mar; 17(2):250-7. PubMed ID: 11921109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.
    Paul KC; Schulz J; Bronstein JM; Lill CM; Ritz BR
    JAMA Neurol; 2018 Mar; 75(3):360-366. PubMed ID: 29340614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study.
    Bjornestad A; Pedersen KF; Tysnes OB; Alves G
    Parkinsonism Relat Disord; 2017 Sep; 42():28-33. PubMed ID: 28578818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features in early Parkinson disease and survival.
    Lo RY; Tanner CM; Albers KB; Leimpeter AD; Fross RD; Bernstein AL; McGuire V; Quesenberry CP; Nelson LM; Van Den Eeden SK
    Arch Neurol; 2009 Nov; 66(11):1353-8. PubMed ID: 19901166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.
    Postuma RB; Iranzo A; Hu M; Högl B; Boeve BF; Manni R; Oertel WH; Arnulf I; Ferini-Strambi L; Puligheddu M; Antelmi E; Cochen De Cock V; Arnaldi D; Mollenhauer B; Videnovic A; Sonka K; Jung KY; Kunz D; Dauvilliers Y; Provini F; Lewis SJ; Buskova J; Pavlova M; Heidbreder A; Montplaisir JY; Santamaria J; Barber TR; Stefani A; St Louis EK; Terzaghi M; Janzen A; Leu-Semenescu S; Plazzi G; Nobili F; Sixel-Doering F; Dusek P; Bes F; Cortelli P; Ehgoetz Martens K; Gagnon JF; Gaig C; Zucconi M; Trenkwalder C; Gan-Or Z; Lo C; Rolinski M; Mahlknecht P; Holzknecht E; Boeve AR; Teigen LN; Toscano G; Mayer G; Morbelli S; Dawson B; Pelletier A
    Brain; 2019 Mar; 142(3):744-759. PubMed ID: 30789229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of prognostic survival models in newly diagnosed Parkinson's disease.
    Macleod AD; Dalen I; Tysnes OB; Larsen JP; Counsell CE
    Mov Disord; 2018 Jan; 33(1):108-116. PubMed ID: 28976022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical heterogeneity of Parkinson's disease and its therapeutic implications.
    Greenland JC; Williams-Gray CH; Barker RA
    Eur J Neurosci; 2019 Feb; 49(3):328-338. PubMed ID: 30059179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease.
    Kwon KY; Kang SH; Kim M; Lee HM; Jang JW; Kim JY; Lee SM; Koh SB
    Can J Neurol Sci; 2014 Sep; 41(5):597-602. PubMed ID: 25373810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
    Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
    Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
    Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F
    Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival in Parkinson's disease. Relation with motor and non-motor features.
    de Lau LM; Verbaan D; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
    Bjornestad A; Forsaa EB; Pedersen KF; Tysnes OB; Larsen JP; Alves G
    Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study.
    Hiorth YH; Alves G; Larsen JP; Schulz J; Tysnes OB; Pedersen KF
    J Neurol; 2017 Feb; 264(2):364-372. PubMed ID: 28000003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and external validation of a prognostic model in newly diagnosed Parkinson disease.
    Velseboer DC; de Bie RM; Wieske L; Evans JR; Mason SL; Foltynie T; Schmand B; de Haan RJ; Post B; Barker RA; Williams-Gray CH
    Neurology; 2016 Mar; 86(11):986-93. PubMed ID: 26888991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.